Research

How digital platforms impact HCP evidence-gathering and influence networks

Overview

Advisory Board hosted working sessions for our cohorts of medical affairs and HEOR leaders in pharma and device to discuss early insights from our research on how digital platforms for medical information-sharing are changing traditional models of evidence dissemination and HCP influence.

On March 24 and 25, we hosted working sessions for our cohorts of medical affairs and HEOR leaders in pharma and device, respectively, to discuss early insights from our research on digital platforms for medical information-sharing. The goals of the meetings were to discuss the implications of our insights for medical leaders’ strategies, identify how the implications of digital platforms are different for pharma and device leaders, and have medical leaders provide input to shape the next phase of our research.

Download the key takeaways to learn the insights shared during the meeting, the key takeaways from the discussion, and the next steps that the life sciences medical affairs and HEOR leaders discussed.

Download the takeaways
X
Cookies help us improve your website experience. By using our website, you agree to our use of cookies.